SCHEMBL20764832

SCHEMBL20764832

Cc1cc(-c2ccccc2)sc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 2/20 0.44
HSD17B2 P37059 2/20 0.44
ESR1 P03372 2/20 0.40
ESR2 Q92731 2/20 0.40
MAPT P10636 8/20 0.40
KDM4E B2RXH2 5/20 0.40
PKM P14618 3/20 0.40
LMNA P02545 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
NPC1 O15118 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
RAB9A P51151 6/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
GAA P10253 4/20 0.39
ALDH1A1 P00352 6/20 0.38
HPGD P15428 4/20 0.38
HSD17B10 Q99714 2/20 0.37
ALOX15 P16050 1/20 0.37
IKBKB O14920 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12174841 0.79 ESR1 (0.31) ESR1ESR2
SCHEMBL18390779 0.78 HSD17B1 (0.61) HSD17B1HSD17B2ESR1ESR2MAPT
SCHEMBL14838409 0.78 HSD17B1 (0.41) HSD17B1HSD17B2ESR1ESR2MAPT
SCHEMBL114000 0.78 HSD17B1 (0.47) HSD17B1HSD17B2ESR1ESR2MAPT
SCHEMBL11522531 0.77 HSD17B1 (0.49) HSD17B1HSD17B2ESR1ESR2MAPT
SCHEMBL10205948 0.77 ESR1 (0.66) HSD17B1HSD17B2ESR1ESR2MAPT
SCHEMBL12757438 0.76 ESR2 (0.38) HSD17B1HSD17B2ESR1ESR2CYP1A2
SCHEMBL6812091 0.75 MAPT (0.40) HSD17B1HSD17B2ESR1ESR2MAPT
SCHEMBL23478902 0.72 MAPT (0.42) HSD17B1HSD17B2ESR1ESR2MAPT
SCHEMBL23449309 0.72 ALDH1A1 (0.44) HSD17B1HSD17B2ESR1ESR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019038362-A1 ANTIBACTERIAL PYRROLOIMIDAZOLONES IDORSIA PHARMACEUTICALS LTD (CH) 2019-02-28 WO disclosed